Valley Baptist Medical Center-Brownsville, Valley Regional Medical Center Initiate New Visitor Policies

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

BROWNSVILLE – Valley Regional Medical Center and Valley Baptist Medical Center-Brownsville have initiated no visitor policies to safeguard their patients, staff, and physicians.

Effective Friday, March 20, 2020, 6 a.m., and until further notice, all patient visitation is restricted with exceptions for laboring mothers, pediatrics, patients undergoing surgery and/or if a patient is in a critical state at end of life. 

While both hospitals understand the importance of in-hospital patients having family members and loved ones by their side, this measure is necessary to ensure the wellbeing of our patients, our healthcare professionals, and the community.

- Advertisement -

With the wider spread of positive COVID-19 cases in the state of Texas, Valley Regional Medical Center and Valley Baptist Medical Center – Brownsville are joining other hospitals to initiate new measures to safeguard colleagues, patients, and medical staff.

The hospitals continue to screen and assess for COVID-19. At this time, the hospitals do not have any confirmed COVID-19 patients.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

STHS & Prominence Health Hosting “Senior Living Seminar” on Malnutrition, Sept. 4th

Malnutrition is often an invisible health concern, quietly undermining an older adult's strength, independence and overall quality of life. Yet its warning signs are frequently overlooked or mistaken for a normal part of aging.

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -